Advanced Medicine

Business & Regulation Profession

07/29/2022 | Angus Stewart | 9 min read

What happened at ISCT 2022’s return to in-person conferencing – and what can a new film release do for advanced therapy?

Business & Regulation Trends & Forecasts

07/21/2022 | Angus Stewart | 9 min read

The International Society for Cell & Gene Therapy convened in person for the first time in two years. We spoke to an attendee for an insight

Business & Regulation Business Practice

07/20/2022 | Angus Stewart | 7 min read

In our third C+G Champions installment, we ask industry leaders in the cell and gene field about accessibility for the many

Manufacture Bioprocessing - Upstream & Downstream

07/15/2022 | Stephanie Vine

The Medicine Maker and NIBRT present the Biopharma Trends Leaders’ Report 2022.

Manufacture Advanced Medicine

06/30/2022 | Sponsored by Charles River | 3 min read

Cell and gene therapy manufacturers need to make better plasmid design decisions with commercialization in mind.

Manufacture Advanced Medicine

06/07/2022 | Maryam Mahdi | 4 min read

What role will CAR-Tregs play in the growing advanced therapy landscape?

Manufacture Advanced Medicine

05/27/2022

Looking for a snapshot of what’s going on in the advanced medicine space? Download our free eBook!

Business & Regulation Profession

05/17/2022 | Maryam Mahdi

Celebrate the people, companies, and innovations had the biggest impact on pharma in the last year.

Manufacture Formulation

05/11/2022 | Gideon Kersten, Daniel Weinbuch, Tim Menzen, Andrea Hawe

Viral vectors can enable innovative medical treatments, but only with a comprehensive formulation development plan

Manufacture Advanced Medicine

05/03/2022 | Angus Stewart

Viral vector manufacture has come a long way, but the story is far from over.